Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1971 1
1975 1
1976 1
1990 1
1993 1
1996 1
1998 1
1999 1
2000 3
2001 2
2002 2
2003 6
2004 6
2005 3
2006 3
2007 5
2008 6
2009 3
2010 1
2011 3
2012 2
2013 3
2014 7
2015 7
2016 7
2017 4
2018 8
2019 9
2020 13
2021 10
2022 22
2023 9

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma.
Alarcon Tomas A, Fein JA, Fried S, Flynn JR, Devlin SM, Fingrut WB, Anagnostou T, Alperovich A, Shah N, Fraint E, Lin RJ, Scordo M, Batlevi CL, Besser MJ, Dahi PB, Danylesko I, Giralt S, Imber BS, Jacoby E, Kedmi M, Nagler A, Palomba ML, Roshal M, Salles GA, Sauter C, Shem-Tov N, Shimoni A, Yahalom J, Yerushalmi R, Shah GL, Avigdor A, Perales MA, Shouval R. Alarcon Tomas A, et al. Among authors: avigdor a. Leukemia. 2023 Jan;37(1):154-163. doi: 10.1038/s41375-022-01739-2. Epub 2022 Nov 5. Leukemia. 2023. PMID: 36335261 Free PMC article.
Early and late hematologic toxicity following CD19 CAR-T cells.
Fried S, Avigdor A, Bielorai B, Meir A, Besser MJ, Schachter J, Shimoni A, Nagler A, Toren A, Jacoby E. Fried S, et al. Among authors: avigdor a. Bone Marrow Transplant. 2019 Oct;54(10):1643-1650. doi: 10.1038/s41409-019-0487-3. Epub 2019 Feb 26. Bone Marrow Transplant. 2019. PMID: 30809033
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.
Garcia-Prieto CA, Villanueva L, Bueno-Costa A, Davalos V, González-Navarro EA, Juan M, Urbano-Ispizua Á, Delgado J, Ortiz-Maldonado V, Del Bufalo F, Locatelli F, Quintarelli C, Sinibaldi M, Soler M, Castro de Moura M, Ferrer G, Urdinguio RG, Fernandez AF, Fraga MF, Bar D, Meir A, Itzhaki O, Besser MJ, Avigdor A, Jacoby E, Esteller M. Garcia-Prieto CA, et al. Among authors: avigdor a. J Natl Cancer Inst. 2022 Mar 8;114(3):436-445. doi: 10.1093/jnci/djab194. J Natl Cancer Inst. 2022. PMID: 34581788 Free PMC article.
Imaging of Hematological Patients in the Era of COVID-19.
Eshet Y, Avigdor A, Kedmi M, Tau N. Eshet Y, et al. Among authors: avigdor a. Acta Haematol. 2022;145(3):267-274. doi: 10.1159/000522323. Epub 2022 Jan 31. Acta Haematol. 2022. PMID: 35100592 Free PMC article. Review.
Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphoma.
Kedmi M, Shouval R, Fried S, Bomze D, Fein J, Cohen Z, Danilesko I, Shem-Tov N, Yerushalmi R, Jacoby E, Besser M, Shimoni A, Nagler A, Avigdor A. Kedmi M, et al. Among authors: avigdor a. Transplant Cell Ther. 2022 May;28(5):251-257. doi: 10.1016/j.jtct.2022.02.017. Epub 2022 Feb 23. Transplant Cell Ther. 2022. PMID: 35218999 Free PMC article. Clinical Trial.
128 results